Friday, March 20, 2020

Old Malaria Drug HYDROXYCHLOROQUINE May Help Cure Coronavirus. Updated

Socio-Political Journal  "A drug developed over half a century ago to treat malaria is showing signs that it may also help cure COVID-19 — especially when combined with an antibiotic, a promising new study reveals.
"Hydroxychloroquine, sold under the brand name Plaquenil — and also used to treat arthritis and other ailments — was determined to be effective in killing the deadly bug in laboratory experiments, Forbes reported, citing findings published March 9 in the Clinical Infectious Diseases journal.
" '(W)e predict that the drug has a good potential to combat the disease,” the study’s authors, most from the Chinese Academy of Sciences in Wuhan, wrote in a letter published in Cell Discovery on Wednesday, according to the report.
"Now, French physician-researchers have completed a largely successful clinical trial using the drug — approved for use in the US in 1955 — to treat confirmed COVID-19 patients, according to a study published Wednesday.
"A total of 36 patients — including 20 treated individuals and 16 infected controls — were enrolled in the study, led by Didier Raoult, an infectious disease expert from l’Institut Hospitalo-Universitaire in Marseille." . . .  More on this here...

Updates:
ABC News: What do malaria and COVID-19 have in common? On the surface, not much. But according to early research, an old malaria drug called chloroquine might also work for the new coronavirus.


Here’s How Long Clinical Trials For Possible Coronavirus Cure Will Take, According To Experts  "Clinical trials to test a malaria drug for use on coronavirus patients could take anywhere from a few weeks to a few months to complete, infectious disease experts said Thursday.

"Scientists who study infectious diseases are cautiously optimistic about using chloroquine or its derivative, hydroxychloroquine, to treat or even cure coronavirus patients after lab studies and a clinical trial in France showed that the malaria medication was effective against the virus." . . .

No comments: